Collaborative Research Centre 841, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dig Dis. 2013;31(1):118-25. doi: 10.1159/000347206. Epub 2013 Jun 17.
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease caused by progressive inflammation of the intra- and extrahepatic bile duct system. PSC patients have an increased risk to develop hepatobiliary as well as extrahepatic malignancies. The goal of a surveillance strategy for hepatobiliary malignancy in these patients is the detection of early cancer which will allow a potentially curative therapy. Here, we focus on a conceptual review of the pathogenesis of cholangiocellular carcinoma and gallbladder cancer and we will discuss a rational approach for the surveillance of these malignancies in PSC patients.
原发性硬化性胆管炎(PSC)是一种慢性胆汁淤积性肝病,由肝内外胆管系统的进行性炎症引起。PSC 患者发生肝胆及肝外恶性肿瘤的风险增加。此类患者肝胆恶性肿瘤监测策略的目标是发现早期癌症,从而进行潜在的治愈性治疗。在这里,我们重点对胆管细胞癌和胆囊癌的发病机制进行概念性综述,并讨论在 PSC 患者中对这些恶性肿瘤进行监测的合理方法。